Literature DB >> 11849866

Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.

Gavin R Norton1, Angela J Woodiwiss, William H Gaasch, Theofanie Mela, Eugene S Chung, Gerard P Aurigemma, Theo E Meyer.   

Abstract

OBJECTIVES: We sought to explore the relative contributions of ventricular remodeling and myocardial dysfunction to heart failure in pressure overload hypertrophy (POH).
BACKGROUND: The mechanism that underlies heart failure in POH is adverse left ventricular (LV) chamber remodeling or decreased myocardial function, or a combination of these.
METHODS: Twenty weeks after suprarenal aortic banding in rats, animals with POH were classified as those with heart failure (POH-HF) or those with no heart failure (POH-NHF). The LV chamber and myocardial systolic and diastolic functions were determined from in vivo and ex vivo experiments.
RESULTS: The LV mass was similar in both POH groups. Chamber remodeling in the POH-HF group was characterized by marked LV enlargement with a normal relative wall thickness (eccentric remodeling), whereas remodeling in the POH-NHF group was characterized by a normal chamber size and increased relative wall thickness (concentric remodeling). The LV systolic function, as determined in vivo from the end-systolic pressure-diameter relationship and ex vivo from the pressure-volume relationship, was lower in the POH-HF group than in the POH-NHF and sham-operated control groups. In contrast, myocardial function was similar in both POH groups, as determined in vivo from the stress-midwall fractional shortening relationship and myocardial systolic stiffness, and ex vivo from the slope of the LV systolic stress-strain relationship. The diastolic chamber stiffness constant was lower in the POH-HF group than in the POH-NHF group, but the myocardial stiffness constant was similar in the two POH groups.
CONCLUSIONS: The two POH groups differed primarily in their remodeling process, which led to a chronically compensated state in one group and to heart failure in the other. Hence, heart failure in POH is more closely related to deleterious LV remodeling than to depressed myocardial function.

Entities:  

Mesh:

Year:  2002        PMID: 11849866     DOI: 10.1016/s0735-1097(01)01792-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

1.  Sustained reversal of left ventricular remodeling following mechanical and pharmacologic therapy.

Authors:  Theo E Meyer
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

2.  Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats.

Authors:  Andrew R Raymond; Bryan Hodson; Angela J Woodiwiss; Gavin R Norton; Richard L Brooksbank
Journal:  Eur J Appl Physiol       Date:  2013-09-06       Impact factor: 3.078

3.  Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.

Authors:  Oleg E Osadchii; Angela J Woodiwiss; Gavin R Norton
Journal:  Pflugers Arch       Date:  2005-12-17       Impact factor: 3.657

4.  Chronic Ethanol Administration Prevents Compensatory Cardiac Hypertrophy in Pressure Overload.

Authors:  Van K Ninh; Elia C El Hajj; Alan J Mouton; Milad C El Hajj; Nicholas W Gilpin; Jason D Gardner
Journal:  Alcohol Clin Exp Res       Date:  2018-05-30       Impact factor: 3.455

Review 5.  Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).

Authors:  Sowndramalingam Sankaralingam; Gary D Lopaschuk
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

6.  Effect of changes in action potential spike configuration, junctional sarcoplasmic reticulum micro-architecture and altered t-tubule structure in human heart failure.

Authors:  M B Cannell; D J Crossman; C Soeller
Journal:  J Muscle Res Cell Motil       Date:  2006-08-04       Impact factor: 2.698

7.  Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.

Authors:  Antoinette Bugyei-Twum; Christopher Ford; Robert Civitarese; Jessica Seegobin; Suzanne L Advani; Jean-Francois Desjardins; Golam Kabir; Yanling Zhang; Melissa Mitchell; Jennifer Switzer; Kerri Thai; Vanessa Shen; Armin Abadeh; Krishna K Singh; Filio Billia; Andrew Advani; Richard E Gilbert; Kim A Connelly
Journal:  Cardiovasc Res       Date:  2018-10-01       Impact factor: 10.787

8.  A new model of congestive heart failure in rats.

Authors:  Jiqiu Chen; Elie R Chemaly; Li Fan Liang; Thomas J LaRocca; Elisa Yaniz-Galende; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-17       Impact factor: 4.733

9.  Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.

Authors:  Kalyani D Panse; Leanne E Felkin; Marina M López-Olañeta; Jesús Gómez-Salinero; María Villalba; Lucía Muñoz; Kazuto Nakamura; Masayuki Shimano; Kenneth Walsh; Paul J R Barton; Nadia Rosenthal; Enrique Lara-Pezzi
Journal:  J Cardiovasc Transl Res       Date:  2012-08-23       Impact factor: 4.132

10.  Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading.

Authors:  Elie R Chemaly; Antoine H Chaanine; Susumu Sakata; Roger J Hajjar
Journal:  J Appl Physiol (1985)       Date:  2012-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.